-
1.(R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity 审中-公开
标题翻译: (R)-CHIRALE卤化1 - 取代的氨基(N + 1)-ALKANOLENAMINO-(N + 1)-ALCANOLS用于抑制胆固醇酯转移蛋白的活性公开(公告)号:EP1589000A2
公开(公告)日:2005-10-26
申请号:EP05011025.3
申请日:1999-09-23
申请人: Monsanto Company
发明人: Sikorski, James.A , Durley, Richard.C , Mischke, Deborah.a , Reinhard, Emily.J , Fobian, Yvette.M , Tollefson, Michael.B , Wang, Lijuan. , Grapperhaus, Margaret.L , Hickory, Brian.S , Massa, Mark.A , Norton, Monica.B , Vernier, William.F , Promo, Michele.A , Hamme, Ashton.T , Spangler, Dale.P , Rueppel, Melvin.L
IPC分类号: C07C215/16 , C07C215/76 , C07C215/50 , C07C217/90 , C07C217/84 , C07D263/06 , C07D251/16 , A61K31/135 , A61K31/33
CPC分类号: C07D207/335 , A61K31/135 , A61K31/33 , C07C215/16 , C07C215/50 , C07C215/76 , C07C217/58 , C07C217/84 , C07C217/86 , C07C217/88 , C07C217/90 , C07C219/34 , C07C225/22 , C07C229/60 , C07C233/69 , C07C235/38 , C07C237/30 , C07C237/38 , C07C255/55 , C07C255/58 , C07C275/34 , C07C291/04 , C07C311/04 , C07C311/21 , C07C311/24 , C07C311/60 , C07C317/32 , C07C317/36 , C07C323/19 , C07C323/25 , C07C323/31 , C07C323/32 , C07C323/37 , C07C323/44 , C07C323/65 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07C2603/18 , C07D209/08 , C07D213/26 , C07D213/30 , C07D213/643 , C07D213/66 , C07D213/85 , C07D239/34 , C07D251/16 , C07D251/42 , C07D263/06 , C07D295/135 , C07D295/192 , C07D307/14 , C07D307/42 , C07D307/52 , C07D309/12 , C07D333/20 , C07D333/28
摘要: The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Novel high yield, stereoselective processes for the preparation of the chiral substituted alkanol compounds from chiral and achiral intermediates are described.
-
2.(R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity 审中-公开
标题翻译: (R)-CHIRALE卤化1 - 取代的氨基(N + 1)-ALKANOLENAMINO-(N + 1)-ALCANOLS用于抑制胆固醇酯转移蛋白的活性公开(公告)号:EP1589000A3
公开(公告)日:2006-03-15
申请号:EP05011025.3
申请日:1999-09-23
申请人: Monsanto Company
发明人: Sikorski, James.A , Durley, Richard.C , Mischke, Deborah.a , Reinhard, Emily.J , Fobian, Yvette.M , Tollefson, Michael.B , Wang, Lijuan. , Grapperhaus, Margaret.L , Hickory, Brian.S , Massa, Mark.A , Norton, Monica.B , Vernier, William.F , Promo, Michele.A , Hamme, Ashton.T , Spangler, Dale.P , Rueppel, Melvin.L
IPC分类号: C07C215/16 , C07C215/76 , C07C215/50 , C07C217/90 , C07C217/84 , C07D263/06 , C07D251/16 , A61K31/135 , A61K31/33
CPC分类号: C07D207/335 , A61K31/135 , A61K31/33 , C07C215/16 , C07C215/50 , C07C215/76 , C07C217/58 , C07C217/84 , C07C217/86 , C07C217/88 , C07C217/90 , C07C219/34 , C07C225/22 , C07C229/60 , C07C233/69 , C07C235/38 , C07C237/30 , C07C237/38 , C07C255/55 , C07C255/58 , C07C275/34 , C07C291/04 , C07C311/04 , C07C311/21 , C07C311/24 , C07C311/60 , C07C317/32 , C07C317/36 , C07C323/19 , C07C323/25 , C07C323/31 , C07C323/32 , C07C323/37 , C07C323/44 , C07C323/65 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/10 , C07C2603/18 , C07D209/08 , C07D213/26 , C07D213/30 , C07D213/643 , C07D213/66 , C07D213/85 , C07D239/34 , C07D251/16 , C07D251/42 , C07D263/06 , C07D295/135 , C07D295/192 , C07D307/14 , C07D307/42 , C07D307/52 , C07D309/12 , C07D333/20 , C07D333/28
摘要: The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Novel high yield, stereoselective processes for the preparation of the chiral substituted alkanol compounds from chiral and achiral intermediates are described.
摘要翻译: 本发明涉及substituiertem芳基和杂芳基(R) - 手性卤化1- Substitutedamino-第(n + 1)链烷醇化合物可用作胆固醇酯转移蛋白抑制剂(CETP;血浆脂质转移蛋白-I)和化合物,组合物和方法 用于治疗动脉粥样硬化和其它冠状动脉疾病。 新颖高收率,对于从手性和非手性中间体手性substituiertem链烷醇化合物的制备立体有择方法描述。
-